These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clofibrate and ischemic heart disease]. Oye I Tidsskr Nor Laegeforen; 1973 Jan; 93(1):33-4. PubMed ID: 4691223 [No Abstract] [Full Text] [Related]
4. [Study of clofibrate. The opinion of Prof. D. Kritchevsky]. Fabbrocini V Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692 [No Abstract] [Full Text] [Related]
5. The value of clofibrate. Hart A N Z Med J; 1978 Jun; 87(613):406. PubMed ID: 277806 [No Abstract] [Full Text] [Related]
6. [Comparative double-blind study on the normolipemic effect of clofibrate and a clofibrate-mucopolysaccharide extract combination]. Cagli V; Lillo V Clin Ter; 1975 Oct; 75(2):153-69. PubMed ID: 132333 [No Abstract] [Full Text] [Related]
7. Clofibrate in the management of hyperlipidaemia. Drug Ther Bull; 1982 May; 20(11):41-3. PubMed ID: 7140522 [No Abstract] [Full Text] [Related]
8. Clofibrate and related compounds in hyperlipoproteinaemia. A review. Gustafson A Postgrad Med J; 1975; 51(8):66-71. PubMed ID: 768950 [No Abstract] [Full Text] [Related]
9. Cholesterol, coronaries, clofibrate and death. Oliver MF N Engl J Med; 1978 Dec; 299(24):1360-2. PubMed ID: 362204 [No Abstract] [Full Text] [Related]
11. Hypolipaemic drugs and coronary heart disease. Howard AN J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209 [No Abstract] [Full Text] [Related]
12. Does hypolipidemic therapy prevent coronary heart disease? Rifkind BM; Levy RI Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303 [No Abstract] [Full Text] [Related]
13. [The study of clofibrate. The viewpoint of Professor D. Kritchevsky interviewed by V. Fabbrocini]. Kritchevsky D Minerva Med; 1979 Dec; 70(55):3808-9. PubMed ID: 523009 [No Abstract] [Full Text] [Related]
14. [Drug prevention of coronary disease]. Miettinen TA Duodecim; 1972; 88(21):1346-54. PubMed ID: 4570871 [No Abstract] [Full Text] [Related]
16. [Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV]. Jantke J; Schwartzkopff W; Zschiedrich M Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():392-5. PubMed ID: 206057 [No Abstract] [Full Text] [Related]
17. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group. JAMA; 1972 May; 220(7):996-1008. PubMed ID: 4337170 [No Abstract] [Full Text] [Related]
18. Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation to clofibrate trial. Carlson LA; Olsson AG Lancet; 1979 Apr; 1(8121):869-70. PubMed ID: 86108 [No Abstract] [Full Text] [Related]
19. WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators. Lancet; 1984 Sep; 2(8403):600-4. PubMed ID: 6147641 [TBL] [Abstract][Full Text] [Related]
20. Clofibrate: a final verdict? Lancet; 1978 Nov; 2(8100):1131-2. PubMed ID: 82687 [No Abstract] [Full Text] [Related] [Next] [New Search]